Anuh Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 20, 2026, recommended Final Dividend of Rs. 1.50 per equity share, subject to shareholders approval in the AGM.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.2 pts less than Nifty Microcap 250 and 6.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anuh Pharma Limited's Board meeting on May 20, 2026 approved multiple items including audited financial results for FY 2025-26 showing revenue of Rs. 77,601.30 lakhs (up 15.6% YoY) but net profit declined to Rs. 4,104.61 lakhs from Rs. 4,735.19 lakhs. The Board recommended a final dividend of Rs. 1.50 per equity share (30% payout on Rs. 5 face value), subject to shareholder approval at the AGM on August 12, 2026 with record date August 5, 2026. Nine promoter group shareholders holding 0.95% stake have sought reclassification from 'Promoter Group' to 'Public' category. Additionally, the Board approved director reappointments, new appointments including GM-Quality and auditors, and adoption of new MOA/AOA.
The dividend of Rs. 1.50 per share represents a 30% payout ratio which is modest. The profit decline despite revenue growth suggests margin compression. The promoter reclassification request could gradually reduce promoter holding in the market.